Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Elizabeth Lord

Orthopaedic Surgery of the Spine Santa Monica, CA Medical Doctor

NPI 1669735973 CMS profile 257694

1250 16Th St Ste 2100, Santa Monica, CA 90404

Open in the dashboard

General payments

$209,802

497 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Elizabeth Lord of Santa Monica, CA is reported in the CMS Open Payments database as having received $209,802 across 497 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 84th percentile of Orthopaedic Surgery of the Spine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $64,858 81
2024 General $56,608 104
2023 General $60,350 124
2022 General $12,117 64
2021 General $3,561 44
2020 General $4,868 30
2019 General $7,439 50

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Elizabeth Lord
  • Orthopaedic Surgery of the Spine median
  • Middle half of Orthopaedic Surgery of the Spine
  • National median

In program year 2025, general payments to Elizabeth Lord were reported at $64,858. Among 1,704 Orthopaedic Surgery of the Spine profiles paid that year, the median was $2,061 and the middle half received between $347 and $14,651.

Show as a table
Year Elizabeth Lord Orthopaedic Surgery of the Spine median Middle half National median
2019 $7,439 $2,106 $337–$18,608 $163
2020 $4,868 $1,213 $156–$15,082 $114
2021 $3,561 $1,834 $271–$15,617 $132
2022 $12,117 $2,015 $320–$17,036 $149
2023 $60,350 $1,925 $336–$14,599 $160
2024 $56,608 $2,110 $341–$12,483 $164
2025 $64,858 $2,061 $347–$14,651 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Globus Medical, Inc. $72,825 121 payments
  2. Medtronic, Inc. $52,040 60 payments
  3. NuVasive, Inc. $24,234 130 payments
  4. SI-BONE, Inc. $22,999 39 payments
  5. Ethicon US, LLC $8,514 4 payments
  6. Medical Device Business Services, Inc. $4,894 18 payments
  7. Alphatec Spine, Inc $4,309 21 payments
  8. Stryker Corporation $3,664 24 payments
  9. IMPLANET America, Inc. $3,167 3 payments
  10. Synthes GmbH $2,083 3 payments
  11. Other $11,073 74 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $121,010 42 payments
  2. Travel and Lodging $41,807 117 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $23,535 4 payments
  4. Food and Beverage $23,450 334 payments
Products named General payments · program years 2019–2025
  1. XLIF $29,139 70 payments
  2. MARS $25,500 5 payments
  3. CD HORIZON SPINAL SYSTEM $22,781 23 payments
  4. IFUSE IMPLANT SYSTEM $21,195 24 payments
  5. UNID_PASS $12,187 16 payments
  6. STRATAFIX $10,374 5 payments
  7. VISTASEAL $10,374 5 payments
  8. SURGIFLO Hemostatic Matrix $10,374 5 payments
  9. DERMABOND $10,374 5 payments
  10. CREO MIS Stabilization System $10,122 4 payments
  11. Other $49,940 303 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 3 drugs

Part D claims

60

Median for Orthopedic Surgery: 203

Drug cost

$730

Median for Orthopedic Surgery: $1,433

Branded share of claims

0%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Gabapentin Generic 35 $406
Tizanidine Hcl Generic 11 $217
Oxycodone Hcl Generic 14 $107

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 58 billing codes

Paid by Medicare

$252,077

Medicare's payments for the services billed

Medicare patients

227

Average age 72

Services billed

794

117 women, 110 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 74%
Depression 33%
Ischemic heart disease 32%
Osteoporosis 27%
Diabetes 24%
Cancer 21%
Chronic kidney disease 17%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

497 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery of the Spine in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record